Cargando…

TGF-β in progression of liver disease

Transforming growth factor-β (TGF-β) is a central regulator in chronic liver disease contributing to all stages of disease progression from initial liver injury through inflammation and fibrosis to cirrhosis and hepatocellular carcinoma. Liver-damage-induced levels of active TGF-β enhance hepatocyte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dooley, Steven, ten Dijke, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250614/ https://www.ncbi.nlm.nih.gov/pubmed/22006249 http://dx.doi.org/10.1007/s00441-011-1246-y

Ejemplares similares

TGF‐β signaling in liver metastasis
por: Marvin, Dieuwke L, et al.
Publicado: (2020)

TGFβ Signaling and Cardiovascular Diseases
por: Pardali, Evangelia, et al.
Publicado: (2012)

E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
por: Sinha, Abhishek, et al.
Publicado: (2021)

Regulation of endothelial cell plasticity by TGF-β
por: van Meeteren, Laurens A., et al.
Publicado: (2011)

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017)

TGF-β-Mediated Epithelial-Mesenchymal Transition and Cancer Metastasis
por: Hao, Yang, et al.
Publicado: (2019)

Targeting TGFβ signal transduction for cancer therapy
por: Liu, Sijia, et al.
Publicado: (2021)

Key role for ubiquitin protein modification in TGFβ signal transduction
por: De Boeck, Miriam, et al.
Publicado: (2012)

Epigenetic Reprogramming of TGF-β Signaling in Breast Cancer
por: Suriyamurthy, Sudha, et al.
Publicado: (2019)

A Perspective on the Development of TGF-β Inhibitors for Cancer Treatment
por: Huynh, Linh Khanh, et al.
Publicado: (2019)

Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer
por: Zhang, Jing, et al.
Publicado: (2020)

Age-dependent alteration of TGF-β signalling in osteoarthritis
por: van der Kraan, Peter M., et al.
Publicado: (2011)

TGF-β Signaling in Breast Cancer Cell Invasion and Bone Metastasis
por: Drabsch, Yvette, et al.
Publicado: (2011)

TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
por: Hua, Wan, et al.
Publicado: (2019)

Editorial: TGF-β and BMP signaling in cancer
por: Yan, Xiaohua, et al.
Publicado: (2022)

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020)

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis—Updated 2019
por: Dewidar, Bedair, et al.
Publicado: (2019)

TGF-β Type I Receptor Signaling in Melanoma Liver Metastases Increases Metastatic Outgrowth
por: Marvin, Dieuwke L., et al.
Publicado: (2023)

TGF-β1 and TGF-β2 abundance in liver diseases of mice and men
por: Dropmann, Anne, et al.
Publicado: (2016)

Opposing USP19 splice variants in TGF-β signaling and TGF-β-induced epithelial–mesenchymal transition of breast cancer cells
por: Zhang, Jing, et al.
Publicado: (2023)

On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?
por: Teixeira, Adilson Fonseca, et al.
Publicado: (2020)

Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling
por: Kurakula, Kondababu, et al.
Publicado: (2015)

Therapeutic targeting of TGF-β in cancer: hacking a master switch of immune suppression
por: van den Bulk, Jitske, et al.
Publicado: (2021)

Targeting TGF-β Signaling by Antisense Oligonucleotide-mediated Knockdown of TGF-β Type I Receptor
por: Kemaladewi, Dwi U, et al.
Publicado: (2014)

Metabolic Reprogramming of Mammary Epithelial Cells during TGF-β-Induced Epithelial-to-Mesenchymal Transition
por: Hua, Wan, et al.
Publicado: (2021)

Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
por: Sow, Heng Sheng, et al.
Publicado: (2019)

FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis
por: Xie, Feng, et al.
Publicado: (2017)

Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells
por: Valdimarsdottir, Gudrun, et al.
Publicado: (2006)

TGF-β Signaling in Progression of Oral Cancer
por: Guo, Yuanyuan, et al.
Publicado: (2023)

TGF-β2 silencing to target biliary-derived liver diseases
por: Dropmann, Anne, et al.
Publicado: (2020)

Fibulin-4 deficiency increases TGF-β signalling in aortic smooth muscle cells due to elevated TGF-β2 levels
por: Ramnath, N. W. M., et al.
Publicado: (2015)

Cancer associated-fibroblast-derived exosomes in cancer progression
por: Li, Chao, et al.
Publicado: (2021)

Fibronectin Protects from Excessive Liver Fibrosis by Modulating the Availability of and Responsiveness of Stellate Cells to Active TGF-β
por: Kawelke, Nina, et al.
Publicado: (2011)

TGF-β-Induced Endothelial to Mesenchymal Transition Is Determined by a Balance Between SNAIL and ID Factors
por: Ma, Jin, et al.
Publicado: (2021)

TGF-β Signaling in Bone Remodeling and Osteosarcoma Progression
por: Lamora, Audrey, et al.
Publicado: (2016)

Contextual Regulation of TGF-β Signaling in Liver Cancer
por: Tu, Shuo, et al.
Publicado: (2019)

Research progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
por: Shi, Ning, et al.
Publicado: (2022)

ST3GAL5‐catalyzed gangliosides inhibit TGF‐β‐induced epithelial‐mesenchymal transition via TβRI degradation
por: Zhang, Jing, et al.
Publicado: (2022)

Imaging the TGFβ type I receptor in pulmonary arterial hypertension
por: Rotteveel, Lonneke, et al.
Publicado: (2023)

Elevated transforming growth factor β and mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease fibroblasts
por: Krause, Carola, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_d4sc0np8ua3tjutrqi6umh6469